BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients
type: MedicalStudy
description: Pharmacokinetics of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine) (BAT®) in Pediatric Patients With a Confirmed or Suspected Exposure to Botulinum Neurotoxin
status: ENROLLING_BY_INVITATION
study design: INTERVENTIONAL
phase: PHASE4
start date: 2014-10
end date: 2028-07-31
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT02051062
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Emergent BioSolutions
study subject: Botulism
keywords: PHASE4
keywords: INTERVENTIONAL
keywords: ENROLLING_BY_INVITATION
keywords: Botulism

AI Analytics
type: Organization